(Updated - June 24, 2026 6:22 AM EDT)

Leerink analyst Marc Goodman initiates coverage on Rapport Therapeutics (NASDAQ: RAPP) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE